{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0685cf-2026-04-19T15:06:48+01:00",
    "date": "2026-04-19T15:06:48+01:00",
    "ocid": "ocds-h6vhtk-0685cf",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-NIC-101788",
            "name": "Queen's University Belfast",
            "identifier": {
                "scheme": "GB-NIC",
                "id": "101788"
            },
            "address": {
                "streetAddress": "University Rd",
                "locality": "Belfast",
                "postalCode": "BT7 1NN",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKN06"
            },
            "contactPoint": {
                "email": "procurement@qub.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "publicAuthoritySubCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - sub-central government"
                    },
                    {
                        "id": "GB-NIR",
                        "scheme": "UK_CA_DEVOLVED_REGULATIONS",
                        "description": "Northern Irish devolved regulations apply"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-NIC-101788",
        "name": "Queen's University Belfast"
    },
    "planning": {
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "Queen's has conducted Preliminary Market Engagement with a number of suppliers in order to: * develop the understanding of our requirements and the proposed approach to the procurement; * gain a better understanding of what the market can offer and if the market was capable of responding to a tender in relation to this requirement; * identify potential suppliers for the requirement; * understand potential lead times; * gain an understanding of the commercial profile for the requirement; * communicate sustainability targets and minimum requirements to confirm the market has the capability to deliver on these. * identify opportunities to reduce the environmental impact of the requirement. The information gathered from PME will be used to shape any forthcoming procurement strategy to ensure that requirements can be subject to reasonable competitive tension. Participation in preliminary market engagement is not a prerequisite for any future tender exercise",
                "dateMet": "2026-03-13T00:00:00+00:00",
                "status": "met"
            }
        ],
        "documents": [
            {
                "id": "035418-2026",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/035418-2026",
                "datePublished": "2026-04-18T23:06:26+01:00",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "260101",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "260101 - Contract for Supply, Delivery, Installation & Commissioning and Maintenance of a High Throughput Live-Cell Imaging System",
        "description": "The Future Medicines Institute (FMI) requires a high throughput live-cell imaging system to enable FMI scientists and collaborators to monitor live cell imaging in real time under optimal conditions of cell growth in a properly maintained carbon dioxide and humidity environment to enable the efficient capture of cellular changes as they happen in the incubator. The objective of procuring a live cell imaging system is to enhance FMI's capacity to monitor cells in real time, in an optimally controlled environment, to support and strengthen its drug discovery capabilities. The proposed system must: * Be capable of multiplate/vessel imaging, up to a capacity of 6 plates/vessels and including capacity to image 6 384 well plates, to meet the volume of analysis that the centre is undertaking and support high throughput drug screening projects. * Enable high resolution fluorescence and bright field images to be captured and recorded in real time over hours, days, or weeks. * Offer flexibility to enable users to observe and quantify complex biological changes over time in cells and 3d structures such as spheroids and organoid models. * Include a fully integrated image acquisition system to capture real-time insight into morphological and phenotypic changes and allow multiple users the opportunity to perform complex cellular assays. * Offer versatile assay configurations, supporting various experimental formats such as 2d cell systems and 3d spheroid, and organoid models. The procurement of this live cell imaging system directly supports FMI's broader goals of: * Accelerating drug discovery through rapid identification and characterisation of therapeutic candidates * Providing screening capabilities in high-throughput format * Facilitating translational research by bridging fundamental cellular studies with therapeutic applications. The procurement of a live cell imaging system will provide direct benefit to research scientists within FMI, and wider stakeholders such as partner organisations and the wider academic community in Queens University Belfast (QUB) by: * Significantly enhance its cellular screening capabilities. * Enhancing live cell imaging capabilities and data acquisition throughput in optimised cellular conditions. * Reducing time in setting up multiple vessels for multiple time point experiments. * Reducing plasticware consumables and expensive reagents currently used in setting up multiple time point experiments. If funding becomes available to address future expansion needs the University reserves the right to purchase additional Live-Cell Imaging Systems during the life of the contract. Subject to the availability of funding, the University may optionally purchase additional Live Cell Imaging Systems during the term of the contract. Any such additional purchases shall be non guaranteed, limited to the optional items and maximum quantities and/or values set out in the Pricing Schedule, and shall have been included in the estimated contract value for the purposes of this procurement.",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "38430000",
                        "description": "Detection and analysis apparatus"
                    },
                    {
                        "scheme": "CPV",
                        "id": "38510000",
                        "description": "Microscopes"
                    },
                    {
                        "scheme": "CPV",
                        "id": "33110000",
                        "description": "Imaging equipment for medical, dental and veterinary use"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKN06",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "UKN06",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "mainProcurementCategory": "goods",
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2026-06-29T00:00:00+01:00",
                    "endDate": "2029-06-28T23:59:59+01:00",
                    "maxExtentDate": "2036-06-27T23:59:59+01:00"
                },
                "hasRenewal": true,
                "status": "active",
                "value": {
                    "amountGross": 975000,
                    "amount": 975000,
                    "currency": "AED"
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price",
                            "name": "Price",
                            "description": "Price",
                            "numbers": [
                                {
                                    "number": 70,
                                    "weight": "percentageExact"
                                }
                            ]
                        },
                        {
                            "type": "quality",
                            "name": "Technical",
                            "description": "Technical (Quality) - ) 30% Comprising of:- * Sustainability - 5% * Ease of use - 10% * Servicing & maintenance - 10% * Lead-times - 5% Compliance with the Mandatory Technical Specification is assessed on a pass/fail basis and is a prerequisite to award",
                            "numbers": [
                                {
                                    "number": 30,
                                    "weight": "percentageExact"
                                }
                            ]
                        }
                    ]
                },
                "renewal": {
                    "description": "option to extend maintenance/consumables, software updates or development, beyond this period for a further period of up to 10 years or the end of useful life of the equipment"
                }
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-04-19T23:59:59+01:00"
        },
        "status": "active",
        "value": {
            "amountGross": 975000,
            "amount": 975000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "aboveThreshold": true,
        "coveredBy": [
            "GPA",
            "CPTPP"
        ],
        "submissionMethodDetails": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home",
        "submissionTerms": {
            "electronicSubmissionPolicy": "allowed",
            "languages": [
                "en"
            ]
        },
        "tenderPeriod": {
            "endDate": "2026-05-20T16:00:00+01:00"
        },
        "enquiryPeriod": {
            "endDate": "2026-05-13T16:00:00+01:00"
        },
        "awardPeriod": {
            "endDate": "2026-06-15T23:59:59+01:00"
        },
        "documents": [
            {
                "id": "L-1",
                "documentType": "biddingDocuments",
                "description": "Queen's Tendering Portal",
                "url": "https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home"
            },
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            },
            {
                "id": "035421-2026",
                "documentType": "tenderNotice",
                "noticeType": "UK4",
                "description": "Tender notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/035421-2026",
                "datePublished": "2026-04-19T15:06:48+01:00",
                "format": "text/html"
            }
        ],
        "contractTerms": {
            "financialTerms": "30 days on receipt of a valid and undisputed invoice"
        },
        "riskDetails": "QUB recognises that certain risks associated with the procurement and operation of a High Throughput Live-Cell Imaging Analysis System are not fully quantifiable at the time of tender. These 'known unknowns' include, but are not limited to, additional requirements, supplier failure and switching costs, technology evolution, integration challenges, data security, regulatory changes, user training & turnover, warranty & service coverage, supply chain disruptions, and software lifecycle changes, increased value or scope due to demand requirements. Suppliers are expected to identify any foreseeable risks, propose mitigation strategies, and demonstrate flexibility in addressing emerging issues throughout the contract lifecycle. Whilst it is not possible at this stage to fully anticipate the nature or extent of future developments or integration requirements, nor to determine their potential impact on contract performance, QUB recognises that such changes may arise over the course of the contract. Accordingly, it is acknowledged that these circumstances may necessitate a modification of the contract to appropriately address and accommodate any emerging risks or requirements."
    },
    "language": "en"
}